OSTEONIC Co., Ltd. (KOSDAQ:226400)
South Korea · Delayed Price · Currency is KRW 6,570.00
-100.00 (-1.50%)
At close: Apr 2, 2026
OSTEONIC Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 45,393 | 34,235 | 27,799 | 19,839 | 15,598 |
Other Revenue | - | - | - | -0 | -0 |
| 45,393 | 34,235 | 27,799 | 19,839 | 15,598 | |
Revenue Growth (YoY) | 32.59% | 23.15% | 40.12% | 27.19% | - |
Cost of Revenue | 23,416 | 17,575 | 14,838 | 11,195 | 9,151 |
Gross Profit | 21,977 | 16,660 | 12,960 | 8,644 | 6,446 |
Selling, General & Admin | 8,395 | 8,098 | 6,950 | 5,690 | 4,403 |
Research & Development | 3,913 | 1,562 | 1,254 | 454.15 | 255.78 |
Amortization of Goodwill & Intangibles | 143.1 | 138.06 | 47.09 | 50.5 | 38.72 |
Other Operating Expenses | 174.07 | 149.46 | 99.19 | 172.76 | 136.06 |
Operating Expenses | 15,813 | 9,774 | 8,118 | 6,118 | 5,867 |
Operating Income | 6,164 | 6,886 | 4,843 | 2,526 | 579.41 |
Interest Expense | -1,164 | -970.47 | -756.43 | -1,373 | -1,606 |
Interest & Investment Income | 235.73 | 337.85 | 369.62 | 213.85 | 151.64 |
Currency Exchange Gain (Loss) | -47.15 | 1,767 | 199.59 | 757.69 | 789.97 |
Other Non Operating Income (Expenses) | 2,908 | -1,497 | -2,370 | 1,970 | -4,528 |
EBT Excluding Unusual Items | 8,097 | 6,523 | 2,285 | 4,094 | -4,614 |
Gain (Loss) on Sale of Investments | 377.66 | 167.5 | -8.84 | -622.33 | -244.81 |
Gain (Loss) on Sale of Assets | -47.55 | 4.85 | 1.33 | 4.72 | -65.24 |
Asset Writedown | - | -56.43 | -496.63 | -1,373 | -513.88 |
Other Unusual Items | - | - | - | -22.42 | - |
Pretax Income | 8,427 | 6,639 | 1,781 | 2,081 | -5,438 |
Income Tax Expense | 928.09 | 989.21 | -1,877 | 1,245 | -2,586 |
Net Income | 7,499 | 5,650 | 3,658 | 835.53 | -2,852 |
Net Income to Common | 7,499 | 5,650 | 3,658 | 835.53 | -2,852 |
Net Income Growth | 32.73% | 54.46% | 337.77% | - | - |
Shares Outstanding (Basic) | 20 | 20 | 19 | 17 | 16 |
Shares Outstanding (Diluted) | 20 | 20 | 19 | 21 | 16 |
Shares Change (YoY) | 2.75% | 4.00% | -10.88% | 37.15% | - |
EPS (Basic) | 374.32 | 285.31 | 193.12 | 49.94 | -182.75 |
EPS (Diluted) | 368.00 | 285.00 | 192.00 | 4.67 | -183.00 |
EPS Growth | 29.12% | 48.44% | 4008.00% | - | - |
Free Cash Flow | 323.57 | -453.42 | -1,968 | 3,504 | 2,006 |
Free Cash Flow Per Share | 15.88 | -22.86 | -103.17 | 163.72 | 128.57 |
Gross Margin | 48.41% | 48.66% | 46.62% | 43.57% | 41.33% |
Operating Margin | 13.58% | 20.11% | 17.42% | 12.73% | 3.72% |
Profit Margin | 16.52% | 16.50% | 13.16% | 4.21% | -18.28% |
Free Cash Flow Margin | 0.71% | -1.32% | -7.08% | 17.66% | 12.86% |
EBITDA | 9,859 | 10,304 | 7,550 | 4,942 | 2,793 |
EBITDA Margin | 21.72% | 30.10% | 27.16% | 24.91% | 17.90% |
D&A For EBITDA | 3,695 | 3,419 | 2,707 | 2,415 | 2,213 |
EBIT | 6,164 | 6,886 | 4,843 | 2,526 | 579.41 |
EBIT Margin | 13.58% | 20.11% | 17.42% | 12.73% | 3.72% |
Effective Tax Rate | 11.01% | 14.90% | - | 59.85% | - |
Advertising Expenses | 485.24 | 520.44 | 422.53 | 288.76 | 154.13 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.